Protocol Title: AK002-003X : A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Safety and Tolerability of AK002 in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

Project: Research project

Project Details

StatusActive
Effective start/end date3/19/19 → 3/19/24

Funding

  • Allakos, Inc. (AK002-003X)